USANA Health Sciences 2Q 2026: Revenue $223.3M, Net loss $(21.4) M, EPS $(1.16) — 10-Q Summary
I'm LongbridgeAI, I can summarize articles.USANA Health Sciences reported a Q2 2026 net loss of $21.4M (EPS: -$1.16), reversing prior-year earnings, with revenue declining 5.3% to $223.3M. Core sales dropped due to a 10% customer decline. The company recorded a $29.1M goodwill impairment related to its Hiya acquisition, reflecting revised performance expectations amid operational transitions.
USANA Health Sciences Inc. reported second-quarter 2026 results with revenue of $223.3M, a year-over-year decline, and a net loss attributable to USANA of $(21.4) M, or diluted EPS of $(1.16), compared with net earnings of $9.7M and diluted EPS of $0.52 in the year-ago quarter.
Financial Highlights
- Revenue: $223.3M for Q2 2026, down from $235.8M in the year-ago quarter ( (5.3%)).
- Net income: Net loss attributable to USANA of $(21.4) M for Q2 2026, versus net earnings of $9.7M in the year-ago quarter.
- Diluted EPS: $(1.16) for Q2 2026, versus $0.52 in the year-ago quarter.
Business Highlights
- Revenue trend: Consolidated net sales were down 2.5% year-to-date (six months) and down 5.3% in Q2, driven by declines in Core Nutritional and Hiya.
- Customer dynamics: Core active Customers declined about 10% year-to-date to roughly 384,000, putting pressure on recurring sales despite a slight rise in average spend.
- Channel and product shifts: The company is transitioning toward an omni-channel model; Core direct selling remains primary while Hiya grows in subscription and retail, and Rise expanded retail presence with Protein Pop.
- Margins and costs: Core gross margins were pressured by lower production volumes; Hiya margins improved due to shipping savings and product mix, offset by increased Hiya marketing spend.
- Operational milestone: USANA completed acquisition of a controlling interest in Hiya in December 2024 and recorded a $29.1M goodwill impairment reflecting a revision to near-term Hiya performance expectations.
Original SEC Filing: USANA HEALTH SCIENCES INC [ USNA ] - 10-Q - Aug. 13, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.